PRESS RELEASE
STOCKHOLM August 30, 2019 – Today Coala Life announces entry into the Dutch market in partnership with Luscii. The Netherlands, with healthcare expenditures approaching $100 Bn, is a major and influential hub in the European medical device industry frequently ranked in the top 5 global medical device markets.
The Swedish medtech company Coala Life, pioneer in digital cardiac diagnosis and user-centered medical innovations, has partnered with Luscii, a leader in remote healthcare and telemonitoring. The two companies will jointly make the Coala Heart Monitor available in the Netherlands through Luscii’s platform. Luscii has previously achieved significant success in supplying patient-centered solutions and their EMR-integrated digital health platform is already in use in nearly 50% of the hospitals in the Netherlands.
- We are very pleased to join Luscii on their exciting journey to make healthcare more efficient. Their digital platform is world class and Coala could not have hoped for a better partner to enter the Netherlands with, says Dan Pitulia, CEO Coala Life AB.
- Cardiologists ask us for best in class ways to support their cardiac patients, such as the growing group with atrial fibrillation. We are thrilled to work with Coala to bring their state of the art innovations to doctors, nurses and their patients on the Luscii platform, comments Dr. Daan Dohmen, CEO Luscii.
The Coala Heart Monitor will initially be available to selected Luscii customers before a full launch. The partnership includes the option to jointly introduce the Coala Heart Monitor in the United Kingdom at a later stage.
For every patient that is registered for home measurement in the coming Heart Week, we will donate to the Hartstichting
It is collection week at the Hartstichting! More than 50,000 collectors are raising money for solutions to keep everyone’s heart as healthy as possible. Luscii wants to contribute too. And our professional users help us during this Heart Week!
They determine the Luscii donation
We have decided to donate a fee to the Hartstichting for every new patient that is registered for home measurement this week. In doing so, we can combine the start of modern care for patients with a contribution to a good cause.
Game rules
At Luscii, we like to keep things simple. Therefore doctors and patients can just register patients in the same way as usual. In the upcoming Heart Week (15th to the 19th of April), we will keep a record of how many patients have been registered. We will not distinguish between different groups (for example, we will also count patients in other Luscii programs, such as COPD). Once the week is over, we will transfer our contribution to the Hartstichting. There is no limit, so the amount raised lies entirely in the hands of our users.
The collection is of vital importance
Living with a heart disease is tough, for the patient and their surroundings. The number of patients is growing rapidly. Therefore, the proceeds from the Hartstichting’s collection will be used to create solutions for keeping every heart as healthy as possible. The Hartstichting is working towards 3 goals:
- The prevention of developing heart problems
- Faster assistance in an emergency situation
- Better treatments, so that patients suffer less
All help is welcome, so that the Hartstichting can find solutions earlier. At Luscii, we think this is important. That is why we are happy to support this goal.
The next charity?
At Luscii, we believe that companies have a responsibility to add something positive to society. And that is something we are very conscious of. This time, we chose the Hartstichting. And with success, we will gladly support another goal next time.
We welcome any ideas for that!
Press Release – Queen Maxima Visits Sensire and NAAST
VARSSEVELD – Clients and employees of Sensire and NAAST were surprised this morning with a visit from Queen Maxima. She visited the organisation to get acquainted with Remote Care, a unique collaboration of digital healthcare in the Achterhoek.
“Thanks to the iPad, I have my freedom back!” This surprising admission was shared with Queen Maxima by 72-year-old Mrs. Mijnten-Schoolderman, during an informal work visit to healthcare organisations Sensire and NAAST. Sensire provides remote care via digital healthcare organisation NAAST to patients with, for example, the lung disease COPD or heart failure. “At first, I didn’t want anything to do with the iPad, but that soon changed”, she says. “I can now decide for myself how my life should be”. Thanks to remote care, patients can decide for themselves when to have contact with care workers. Patients are given an iPad with special software from Luscii, a start-up that develops smart software for remote care. Via video calling, they can make contact with nurses and other specialists who provide care from a distance. “Do you know what the real beauty of it is? The people at NAAST know me and my situation. So I don’t have to tell my story over and over again”.
“The visit of Queen Maxima demonstrates that something really special is happening with healthcare in the Achterhoek”, says Maarten van Rixtel, Director of Sensire. Digital resources and techniques are being implemented into healthcare in more places across the Netherlands. “What makes our commitment special is the scope and the fact that we, as different organisations, work together”, says Van Rixtel. An intensive collaboration exists between Slingeland Hospital and health insurer Menzis in the area of remote care.
Sensire has been a pioneer of digital care since 2009 and has remained closely involved with Luscii since 2014, who specialise in healthcare innovation. “Giving people an iPad is not that difficult”, says Daan Dohmen of Luscii. “The point is to build and deploy the technology in such a way that customers regain control”.
Slingeland Hospital sees remote digital care as an important means of getting closer to the patient. “As a hospital, you are actually always too late”, says Erwin Bomers, Director of Healthcare Policy at Santiz Hospitals. “With remote care, you get very close to your patients: in their own home environment. As a result, you have a better picture of the situation, and our people are able to ask other questions”.
For Menzis, collaboration with healthcare organisations, such as Sensire and Slingeland Hospital, is a special step. Olivier van Noort, Senior Healthcare Purchaser at Menzis: “The exceptional thing is that we really entered into this together: we share the risks and the benefits”. Remote digital care not only gives customers more control, it also offers an important means to continue to make healthcare possible in the future.
Healthcare organisations join forces for people with COPD
Starting today, residents of the Kennermerland region with the pulmonary disease COPD can now use the network ‘COPD in the neighbourhood’. Thanks to the dedicated App, they can monitor the course of their illness and contact healthcare professionals remotely via video calling. The advantages for people with COPD include reducing the need for hospital visits, gaining more control over their lives and improving that feeling of safety, as specialised nurses are available for contact day and night. COPD in the neighbourhood is made unique through the intensive cooperation between healthcare providers in the neighbourhood, the hospital and innovative partners that make remote care possible.
“COPD in the neighbourhood”
‘COPD in the neighbourhood’ is a collaboration between healthcare organisations that want to improve care for people with COPD. One of the initiators is Peter Paardekooper, from Huisartsen Centrum Zandvoort. “For people with COPD, hospital visits are strenuous because of their limited lung capacity. In addition, the checks are arranged at fixed times, meaning we are not always there when the care is really needed. Thanks to our new remote monitoring service, that is now possible; patients can securely exchange information with doctors and nurses, and make video calls on a tablet via the dedicated Luscii app. In this way, patients gain insight into their lifestyle and its influence upon their health. Then, we only need to make appointments in the hospital if it is necessary”.
Unique collaboration
What makes the project special is that all parties involved in the care for people with COPD have joined forces: general practitioners cooperative Zuid-Kennemerland, network of physiotherapists FysiQ, healthcare organisations Kennemerhart and Zorgbalans, the Spaarne Gasthuis, health insurer Zilveren Kruis and innovative partners that make ‘remote care’ a reality. In an initial pilot scheme, the idea of ‘COPD in the neighbourhood’ proved to be successful: now the time has come for the next step. Paardekooper: “What’s new is that we can now offer 24/7 care through video calling and use of the Compaan, a user-friendly tablet. With remote monitoring, we bring second-line care to the ‘zero-line’, at home with the patient. That gives him or her much more freedom”.
Safe feeling
The 24/7 remote care is carried out by the nurses of Medisch Service Centrum NAAST. If necessary, they can call in one of the other healthcare professionals, for example, for a home visit. René Baljon, director of NAAST: “Our years of experience with remote care for hospitals can now benefit general practitioners. We stand beside the healthcare professional and the patient, and that gives them a safe feeling. With remote care, the actual care becomes a less prominent part of your life and that makes it incredibly valuable”.Fast information exchangeAll healthcare providers, such as the district nurse, practice assistant, lung nurse and the physiotherapist, remain informed over the course of the disease via the communication platform OZOverbindzorg.
Paardekooper: “Together, we give the patient control, he or she determines which care providers receive access. They can exchange information as quickly as possible and take action when necessary”. COPD in the neighbourhood will begin, in this new set-up, with 50 patients. Paardekooper: “In 2019, we wish to expand this further and make remote monitoring possible for all people with COPD in the Kennemerland region”.
Baljon supports that ambition. “It has recently been agreed in Parliament that remote care is to be made available for everyone with COPD and heart failure, across the Netherlands, within the next three years. That is where the collaboration in Kennemerland fits in seamlessly. We are ready to scale up together”.
Made possible by
The project “COPD in the neighbourhood” is made possible by the uniting parties: GPs Cooperative Zuid Kennemerland, Spaarne Gasthuis, FysiQ network, Luscii, Kennemerhart, Medisch Service Centrum NAAST, Compaan, Zorgbalans, OZOverbindzorg and Zilveren Kruis.
This press release was published by NAAST on 11 November 2018 in Dutch (https://www.icthealth.nl/nieuws/zorgorganisaties-bundelen-krachten-voor-mensen-met-copd/)
Noordwest Ziekenhuisgroep and Luscii start pilot
The Heart-Lung Centre of the Noordwest Ziekenhuisgroep (Northwest Hospital Group) starts its Telemonitoring pilot with Luscii. With Telemonitoring, patients are followed remotely by a medical specialist and/or nurse specialist while carrying out medical check-ups from home. This means they won’t have to visit the outpatient clinic every time.
During the pilot phase, Noordwest Ziekenhuisgroep will ask 25 heart failure patients and 25 COPD patients to participate for a period of 6 months. The project is a collaboration between Noordwest Ziekenhuisgroep and Luscii.
Signing
Today Floor Haak, member of the Board of Directors of the Noordwest Ziekenhuisgroep and Daan Dohmen, founder of Luscii, signed the collaboration agreement for Telemonitoring using Luscii. “This project is great because it is a way to deliver care in a very patient centred and future proof manner. Care of high quality, delivered at the right place”, said Floor Haak.
The signing itself was also completed in an innovative way, using the video communication to practice what we preach. On the photo (from left to right): Jan van Ramshorts (cardiologist), Victor Umans (cardiologist), Daan Dohmen (on the screen), Floor Haak (member of the Board of Directors) and Wendy Burgersdijk (pulmonologist).
Photo by Noordwest Ziekenhuisgroep/Pierre Mettes
This press release was published by Noordwest Ziekenhuisgroep on 6 November 2018 (https://www.nwz.nl/Nieuws-NWZ/ArtMID/6077/ArticleID/865/Noordwest-en-Luscii-starten-pilot-Telemonitoring)
In the midst of the summer holidays, healthcare insurer Zilveren Kruis introduced a unique financing model for hospitals who want to offer telemonitoring at home for their patients. The news is a breakthrough for thousands of citizens that suffer from heart disease. Together with Menzis – who previously introduced unique funding for COPD monitoring – the insurers show that this innovation is not just a whim for them. Now, what does this mean for hospitals and patients?
Financial paradox for eHealth
Despite all the promises, eHealth is not widely available for every patient. A major cause being the current funding system. Though VBHC (Value Based HealthCare) sounds inspirational, nowadays reimbursements for specialist medical care are based on the number of actions that have been carried out. In short; a hospital gets paid when patients visit the doctor or the outpatient clinic, or are admitted. In contradiction, many eHealth solutions – including home measurement – aim to prevent care. And that’s a catch 22; Costs to the hospital increase when introducing home measurement tools, while turnover decreases because fewer interventions or admittances are needed. From an insurer or payer or citizen perspective this is a win (we all pay taxes and fees for insurance). But this does not work for the hospital and the doctor… What now?
The start of new financial models for home monitoring
In 2016, Zilveren Kruis, Cardiology Centers the Netherlands (CCN) and FocusCura entered into a long-term partnership to bring as much hospital care as possible to the homes of patients. They launched the “HeartGuard” concept, watching over patients with heart failure, hypertension and atrial fibrillation. Part of this concept would also include a completely new way of funding, and that was easier said than done…
Over the course of nine months, an innovation team representing all three parties worked on the concept. They shared the vision that care should be delivered tailor-made to the patient’s needs, and while monitored safely at home with technology, a hospital visit would only be necessary in case of urgency. This approach improved the patients’ service-experience tremendously, while at the same time, the cost of care was reduced: Admissions are prevented and outpatient care is partially substituted. The calculation model of the innovation team was tested at CCN, and after testing the ‘Hartwacht fee’, would be made widely available by Zilveren Kruis. And that moment is now.
Bundled payments
The concept is based on the principle of ‘bundled payments’. An insurer pays the hospital a bundled price per care pathway. The price being determined upon the historical price of the mix of healthcare products in the concerned care pathway. Though this seems complicated, basically it comes down to the hospital always receiving a guaranteed rate per pathway. Regardless of whether the patients visit the outpatient clinic, are hospitalised or are monitored remotely through home monitoring and videocare. Caregivers can thus determine, without financial consequences, in consultation with their patients, what is best for them. And if they decide to use the home monitoring, there are no additional costs for the patient, since they are paid for in the bundle price.
Does it work for the patients?
From my own experience, I can tell what this means for patients. Kor: “Someone in my immediate family has heart problems. He had to go to the hospital very regularly. Sometimes for a routine check-up, even though he had no complaints. Another time in panic to the emergency room. Fortunately, he has a modern cardiologist who prescribed ‘HeartGuard’”.
Kor received measuring equipment at home and the Vitals app was installed on his phone. During the first ‘setting week’, a personal measurement protocol was set up. Now he sends in his measurements weekly and he no longer has to visit the clinic. “I remember how ‘happily surprised’ he was after being ‘videocalled’ by the HeartGuard Centre, when it appeared that there were strange values in his measurements. His medication was adjusted and altogether this gave him such peace of mind. Not only for him, but also for us, as his direct family”.
More time for cardiologists
And besides, his own cardiologist was extremely satisfied. He now has insight into all home measurement data in the EMR and remains Kor’s regular point of contact for those moments when something is really off. According to a jointly agreed protocol, home measurements are treated in the HeartGuard Centre in Dokkum. The HeartGuard data shows that less than one in ten measurements have to be forwarded to the cardiologist. The rest of the home measurements are handled by the Vitals app itself or the HeartGuard team in Dokkum.
For Kor’s cardiologist, this means that many urgent questions popping up in his busy schedule, now belong in the past, while patients immediately have clarity about their condition and possible risks. He can thus have more patients under his supervision. And his own work is more pleasant, he said, because he can do his job even better by intervening proactively and by using the data for the benefit of his patients.
2019: Extra financial incentive
To make this widely available, Zilveren Kruis goes a step further; they commit to a fixed bundle price for three years. So hospitals will receive the same bundle price over the next three years, regardless of how their operational costs of the outpatient clinic decrease or the number of admissions decreases. Hospitals are allowed to keep the margins themselves and are given the time to adjust to the new way of care. A huge incentive!
Sharing knowledge to better care
It is very cool to be able to contribute to this movement with our team. We are happy to share our knowledge gained through various channels, such as in this blog. Because I hope that other hospitals will now also take the step. Since not only my Kor, but all heart patients, deserve the best care that fits their needs. VBHC then becomes a practice.
Or like my inspiration Florence Nightingale stated:
“Were there none who were discontented with what they had, the world would never reach anything better.”
This blog was published in Dutch on the website of Qruxx about Value Based Healthcare in August 2018.
The innovative project ‘COPD InSight’ won theVBHC Primary Care Award 2018 on April 26th. COPD InSight is an initiative of…
At the start of the Dutch e-Health Week, RKZ-patients will receive their tablets with the Luscii Vitals (formerly cVitals) and Luscii Contact (formerly cContact) applications. They will use them to monitor their vital signs directly from home.
The Luscii Vitals app on the tablet will provide the patients with information about their disease, self-management tips and support when having health problems related to their COPD. Over the following months, they will fill out a questionnaire weekly and whenever Luscii detects deterioration of their health situation, Luscii will inform the pulmonary nurse of VIVA Homecare directly. The nurse will then visit the patients at home or use Luscii videocare for a virtual consultation. If needed, they can refer to the pulmonologist or pulmonary nurse directly at the Rode Kruis Hospital.
Pulmonologist Erik Kapteijns: “We are going to treat these patients much more intensively without them needing to visit the outpatient clinic. By acting earlier, patients will have less exacerbations and a more stable development of their disease”.
Luscii will provide its digital health platform with apps for the patients and hospital users. Through this digital health platform, data will be managed and sent securely. The first step is to test and optimise the care pathway with a smaller group of patients. When successful, it will be scaled further.
Part of this article was published in Dutch on the website of RKZ in January 2017. A follow up article was published in print in May 2018.
The Martini Hospital starts, in collaboration with Luscii (previously ‘FocusCura’), two innovative projects to monitor patients with a chronic disease remotely and thereby prevent hospitalisation. Patients with COPD or heart failure receive a tablet at home, on which they transmit medical information about their condition to the hospital on a daily or weekly basis. If a patient exceeds their specific threshold value, the hospital will contact the patient via video calling. For example, medication can be adjusted at an early stage to ultimately prevent hospitalisation. In addition, it increases the degree of self-management, the feeling of safety and the quality of life of patients.
Hans Feenstra, the Martini Hospital’s chairman of the board: “These projects are a good example of ‘The right care in the right place’. We believe that, in principle, care should be organised as close to the patient as possible and we are therefore actively engaged in this”.
Patients who are already being treated by the hospital can participate in these projects. It is not the aim to relocate care to the general practitioner (substitution). This effective care is not only adding value for patients, it also reduces the costs of healthcare. Emergency admissions can be prevented and fewer outpatient visits are necessary. Feenstra: “The projects give substance to the long-term agreements that we have with healthcare insurers Menzis and Zilveren Kruis. We have committed to develop initiatives for care close to the patient.” Both projects start with a small group of patients in order to gain experience with this new way of working. Also, in collaboration with Luscii, scientific research into the results of telemonitoring is being conducted.
Prevent an exacerbation
COPD is a lung disease in which the lungs are damaged. The lungs fail to provide adequate breathing and the patient has less energy. COPD is characterised by lung attacks, in which the patient experiences more stuffiness, coughing and production of mucus, which often results in hospitalisation. We want to prevent these exacerbations by means of more frequent monitoring. Patients suffering from severe COPD fill in a validated questionnaire every week, containing questions about how the patient feels. A specialised nurse monitors the outcomes in the hospital. If these outcomes exceed certain threshold values, the nurse will contact the patient via a video consult. This way she can literally see how the patient is doing and can, for example, adjust the medication. This may possibly prevent an exacerbation. For patients with COPD, the trip to the hospital is very exhausting, as it often requires a great physical effort. Therefore this type of remote care is very suitable for them.
Titration of medication
Heart failure is a condition in which the pumping function of the heart decreases slowly or abruptly. As a result, patients get tired faster, develop fluid retention and experience shortness of breath in daily activities. Patients with heart failure transmit measurements of their weight, blood pressure and heart rate to the hospital daily, using the iPad. Therefore, these patients do not only receive an iPad, but also a weighing scale and a blood pressure meter at their disposal. Telemonitoring for heart failure is highly suitable for patients who have just been diagnosed with heart failure and for patients who are in an unstable phase of their condition. In both groups, the medication must be properly set or reset. And where that normally happens over a period of eight weeks through a series of visits to the outpatient clinic, it is expected that this can now be done in just a few visits and in just a few weeks. Adjusting the medication and explaining the condition and lifestyle will now take place via video contact, so that the patient does not have to visit the hospital. It is also expected that emergency admissions will be prevented. In addition, the patient is actively involved in his or her care process through this form of telemonitoring. Research shows that more control and self-management increases the patient’s quality of life.
This article was published in Dutch on the website of Martini Hospital in July 2018.
The Department of Pulmonary Diseases at the Isala Hospital started with digital homemonitoring for COPD patients via Luscii Apps in 2017. Patients in the project don’t have to come to the hospital as often and have a lower risk of hospital admissions as well. The check-ups of the patients are completed remotely, with home measurements taken twice a week using the Luscii Apps. If Luscii detects deterioration, the nurses at Isala will be informed and will reach out immediately. The project is accompanied by research carried out by Martine Breteler MSc, working together with different people at the Isala Hospital, including pulmonologist Jan Willen van den Berg MD, PhD.
The Dutch Ministry of Health made a video of this great project and showcased it as an example of the eHealth movement in the Netherlands during the eHealth Week:
Mr. Foederer suffers from heart failure, a serious condition in which the heart’s pumping function continues to decrease. As one of the first patients of the Haga Hospital’s Heart Centre and in the region in general, he is now under supervision at home via ‘Cardio@Home’. The doctor or nurse sees all measurement results and can intervene quickly if a situation changes.
In the Netherlands, about 150,000 patients are suffering from heart failure. There are many disorders that can cause heart failure: a heart attack, high blood pressure, cardiac arrhythmias, cardiomyopathy, valvular heart disease, inflammation of the heart muscle or a congenital heart defect. “Although the medication continues to improve, the condition is unfortunately as yet incurable”, explains cardiologist Ivo van der Bilt. “Half of these patients have a life expectancy of 5 years after the diagnosis, so it is a serious condition that calls for proper support of the patient and family. The Haga Heart Centre has an outpatient clinic with specialised nurses for heart failure. Here, we recently started the project Cardio@Home”.
More measurements, less hospital visits
“The patients that participate in the project Cardio@Home are now monitored more often, while they have to visit the hospital less often”, says heart failure nurse Arjan te Hoonte. “They receive an iPad, a wireless blood pressure monitor and a weighing scale for 6 months. The equipment is delivered and installed at the patient’s home by the supplier Luscii (previously ‘FocusCura’). At home, the patient measures his or her weight and blood pressure 2x a week. The results are sent to us via an app and we assess them immediately. We also ask the patient to fill in a questionnaire regularly, which contains questions about shortness of breath and fatigue during the measurements. This helps us in evaluating the measured values. In addition to the regular check-ups in the hospital, now we can also monitor and check on the patient remotely, adjust medication or give other advice, and if necessary, we can video call the patient via the iPad”.
Arjan is very enthusiastic about this development. It helps the patient to feel safer and to reduce the the hospital visits. “We also ask about the level of satisfaction, to make the quality of life visible. It provides us with a lot of information for scientific research, which helps us to adjust policies and to continue the use effectively”.
Safe and secure
Mr. Foederer feels comfortable with monitoring at home. “I do not have to go to the hospital as often, and if there is something strange, I can take action immediately. I can have a call with the nurse through the iPad. The nurse also called me once when my weight suddenly went up. He wanted to know if I was also developing fluid retention around my ankles. Now I’m being watched closely, but remotely”.
E-health has become an integral part of healthcare
Ivo van der Bilt considers this form of e-health a valuable addition to healthcare. “Innovative e-health facilities are used increasingly as part of the care process in healthcare.Thanks to Cardio@Home, these vulnerable patients can live independently at home for as long as possible. We can reassure the patient remotely, but also intervene faster if the situation worsens. With medication adjustment, for example, we can prevent a visit to the Emergency Department and maybe even a hospital admission, which is a reassuring thought for the patient”.
This article was published in Dutch on the website of Haga Hospital in December 2017.
People often question the proof of innovation in healthcare, for example, in projects such as COPD InSight or HeartGuard. Which is no small thing, considering so many innovations are implemented ‘on top of’ current healthcare, making it unnecessarily expensive. Just what do we mean by ‘proven’? What evidence already exists?
In this blog, Martine Breteler and Daan Dohmen will guide you through these questions. We can define the success of digital care as consisting of three categories of ‘evidence’, otherwise referred to as the Triple Aim principle. While it may be a slightly informal term, it actually just means ‘a healthy population’, ‘a better qualitative experience of healthcare’ for ‘relatively lower costs’. What evidence already exists?
Telemonitoring makes people healthier
For the first type of evidence, we will look at the effects of digital care, specifically that of telemonitoring in the population. In short, do patients experience fewer symptoms? Has there been a reduction in patients with worsening symptoms? Has there been an improvement in patients’ blood pressure?
A brief look at scientific articles indicates that there is a growing body of evidence worldwide showing this to be the case. Cardiologist Dr. Milani convincingly proved that virtual care for hypertension using connected devices has delivered a huge improvement (Milani et al. Am. J. Med. 2016). No less than 71% of patients diagnosed with high blood pressure achieved their goal to manage their blood pressure (with an average improvement of 14/5 mmHg) after three months, compared to 31% of patients who received regular care.
In addition to the hypertension patient group, other patient groups saw significant improvements to their health. One of the largest telemonitoring experiments in the world, the famed ‘Whole System Demonstrator’ programme, showed promising results based on its test group of 3,230 patients who had been diagnosed with either diabetes, COPD, or heart failure. This cluster randomised controlled trial showed a significant reduction in the number of fatalities and the number of visits to the emergency room among patients who used telemonitoring, compared to the control group.
Our own project reviews also show promising results. One review of 77 patients suffering from heart failure or COPD showed that among patients suffering from heart failure, 42% experienced fewer symptoms, and 69% felt more independent. Among COPD patients, this was 28% and 52% respectively. However, it is important to remember that these results were reported in specific patient groups whose doctor or healthcare specialist had ‘prescribed’ for measurements to be performed at home. So the question remains, in spite of these great results, whether this change is only temporary in nature. To achieve this result in the long term, it is even more important that patients themselves actually want to keep using telemonitoring.
Patients want it!
The second type of evidence is possibly the most important – improvements to a patient’s perception or experience. This may seem like a ‘softer’ type of evidence compared to the efficacy of studies of effectiveness. Then again, Uber and booking.com didn’t need to scientifically verify that their way of doing things was better than the way it used to be, did they? It’s the consumers who appreciate their services more, and therefore choose to keep using them.
In the healthcare industry, the number of options to choose from is limited. Patients are dependent on the suppliers, yet there are hardly any major differences between those suppliers. Meanwhile, we have already deployed telemonitoring in hospitals and are seeing impressive results among patients. A review among 23 patients of the St. Anna Hospital, Zuidzorg, and SGE show that 92% have experienced improved healthcare. Our test group of patients suffering from COPD and heart failure showed that 81% of patients with heart failure and 68% of patients with COPD experienced better healthcare.
Looking at HeartGuard, the first effect measurement among patients with resistant hypertension, who had been referred to second-line care and now receive remote support, improved these patients’ quality of life (measured using EQ-5D-5L) and increased their level of self-management (measured using PAM-13).
We shouldn’t really suggest that there is a link between the results shown in our test groups, which are still limited, and the existing body of scientific literature, yet we see similar results among patients who use telemonitoring as well. A large study was conducted among 851 vulnerable elderly patients suffering from COPD, heart failure, diabetes, or hypertension who had just been discharged from the hospital to investigate the effects of telemonitoring (Cardozo and Steinberg, Telemed J E Health 2010). This study showed that telemonitoring, defined as the daily measurement of vital signs combined with regular nurse visits, increased beneficial outcomes for elderly patients as well. 66% of patients thought that the quality of healthcare provided had improved, with customer satisfaction easily reaching 90%.
Again, the way in which measurements at home are performed – which specific patient group, which technology, and which type of intervention – is clearly a determining factor in the results. Behavioural scientists still have a lot to explore in this area. There is also a great deal left to research about the long-term effects, as many studies run over a limited time frame. Whatever happens, it’s going to be interesting!
Of course, although there’s no doubting the huge role played by scientific research in this area, we think it’s just as important to simply talk to patients and keep listening to their experiences. It really gives you a boost when patients themselves tell you what this service means to them.
Lower cost of care when using telemonitoring
It’s no simple matter to measure whether the cost of care provided decreases when using telemonitoring, mainly due to the way that care is ‘calculated’. However, scientific research concluded that the use of telemonitoring led to a reduction in the number of COPD patients with worsening symptoms, a reduction in hospital admissions, and a reduction in overall costs.
Seto’s systematic review of nine studies (Telemed J E Health. 2008) shows when comparing the cost of use of telemonitoring to the costs of regular healthcare, the total costs decreased in all studies as a result of telemonitoring, varying between 1.6% and 68.3%. This can be primarily attributed to the decrease in re-admissions. The figures may vary slightly due to differences in the telemonitoring system used, the variety of protocols, and the number of hospitals studied. However, this is still a promising piece of evidence that telemonitoring has a positive financial impact.
The aforementioned decrease in the use of healthcare has an even more significant effect. If we can treat the same number of patients with less labour but for equal or reduced costs, this will give a boost to the ever increasing shortage of staff in the healthcare sector.
So far, the initial results of research on these three types of ‘evidence’ reveal very promising outcomes as far as the use of telemonitoring is concerned. We realise that the body of scientific evidence is still scarce, so there’s still lots of work to be done!
Dilemmas when researching eHealth
For quite some time now, we’ve been trying to establish a generic experiment, intended to test the effectiveness of telemonitoring for COPD patients on a large scale, bridging multiple healthcare organisations. Establishing the correct research design has already proven to be problematic. Although the ‘randomised controlled trial’ (RCT) provides the most credible evidence available, there are various reasons why it’s an unsuitable method for researching the effects of telemonitoring.
A telemonitoring app is in a constant state of development, for example. Our developers regularly publish an updated version of the Luscii Vitals telemonitoring app with improvements for the patient or care provider. This makes a reliable comparison between the test and control group on the impacts of it impossible.
We consider it to be bordering on unethical to exclude patients who wish to participate because we know what it can mean for them (even though we probably shouldn’t be saying this out loud as scientists). Randomising who does and who does not receive telemonitoring is therefore not an option.
No “one size fits all”
How should we do it, then? To avoid reinventing the wheel, we have to take a really close look at scientific literature when establishing a research design.
In concrete terms, this means that telemonitoring is a medical intervention that needs to be implemented in a targeted way – it’s not suitable for every patient. We absolutely must listen to doctors who have ‘prescribed’ telemonitoring and assess how telemonitoring has been embedded in the healthcare process.
Literature increasingly supports this line of thinking. For instance, this month’s edition of Nature featured a meta-analysis of sixteen reliable randomised controlled trials. This showed that telemonitoring as a generic tool for ‘every patient’ has almost no significant benefit, while the proper use of telemonitoring for specific patient groups is very promising (Noah et. al, 2018).
How should we design our multi-centre research?
Unfortunately, there is no such thing as a “one size fits all” research design. After consulting different healthcare professionals, we have come to the conclusion that we need a control group if we want to report useable results. We have chosen a research design, together with Dr. Joris Jansen and in collaboration with professor of Data Science & Health Maurits Kaptein, that uses a matched control group consisting of patients who do not use telemonitoring.
Learning, doing, and researching at the same time
A single experiment won’t be enough to address all the research questions that require more ‘evidence’. Besides, we’re not aiming to conduct only one big experiment, live in a bunker, and await the results before continuing our work. Far from it. You really can’t put a price on the valuable information we obtain from studying continuous results. This targeted approach helps us provide practical applications of the ‘lessons learned’ about implementing an eHealth service. It’s all about learning, doing, and researching at the same time.
Meaning even more to patients
Of course, we want telemonitoring to be part of regular healthcare for patients who could benefit from it, including the funding that comes with it. Because, however complex it is to perform research, simply listening to patients’ experiences in our projects has shown us how we can mean so much more to these people. Given the expected rise in the number of patients, this will be more crucial than ever!
Sources
- Milani, R. V., Lavie, C. J., Bober, R. et al. (2017). Improving Hypertension Control and Patient Engagement Using Digital Tools. The American Journal of Medicine, 130(1), 14-20.
- Dransfield, M., Wells, M., & Bhatt, S. (2013). Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial.
- Cardozo, L., & Steinberg, J. (2010). Telemedicine for Recently Discharged Older Patients. Telemedicine and e- Health, 16(1), 49-55.
- Seto, E. (2008). Cost Comparison Between Telemonitoring and Usual Care of Heart Failure: A Systematic Review. Telemedicine and e- Health,14(7), 679-686
- Noah, B., Keller, M.S., Mosadeghi, S., et al. (2018). Impact of remote patient monitoring on clinical outcomes: an updated meta-analysis of randomized controlled trials. Nature partner journals Digital Medicine 1, Article number:2